Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

105 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Alpha-synuclein inclusions in Alzheimer and Lewy body diseases.
Mukaetova-Ladinska EB, Hurt J, Jakes R, Xuereb J, Honer WG, Wischik CM. Mukaetova-Ladinska EB, et al. Among authors: wischik cm. J Neuropathol Exp Neurol. 2000 May;59(5):408-17. doi: 10.1093/jnen/59.5.408. J Neuropathol Exp Neurol. 2000. PMID: 10888371
A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy.
Schwab K, Frahm S, Horsley D, Rickard JE, Melis V, Goatman EA, Magbagbeolu M, Douglas M, Leith MG, Baddeley TC, Storey JMD, Riedel G, Wischik CM, Harrington CR, Theuring F. Schwab K, et al. Among authors: wischik cm. Front Mol Neurosci. 2018 Jan 10;10:447. doi: 10.3389/fnmol.2017.00447. eCollection 2017. Front Mol Neurosci. 2018. PMID: 29375308 Free PMC article.
Lewy body variant of Alzheimer's disease: selective neocortical loss of t-SNARE proteins and loss of MAP2 and alpha-synuclein in medial temporal lobe.
Mukaetova-Ladinska EB, Xuereb JH, Garcia-Sierra F, Hurt J, Gertz HJ, Hills R, Brayne C, Huppert FA, Paykel ES, McGee MA, Jakes R, Honer WG, Harrington CR, Wischik CM. Mukaetova-Ladinska EB, et al. Among authors: wischik cm. ScientificWorldJournal. 2009 Dec 16;9:1463-75. doi: 10.1100/tsw.2009.151. ScientificWorldJournal. 2009. PMID: 20024519 Free PMC article.
Tau-aggregation inhibitor therapy for Alzheimer's disease.
Wischik CM, Harrington CR, Storey JM. Wischik CM, et al. Biochem Pharmacol. 2014 Apr 15;88(4):529-39. doi: 10.1016/j.bcp.2013.12.008. Epub 2013 Dec 19. Biochem Pharmacol. 2014. PMID: 24361915 Free article. Review.
105 results